Earnings Preview For Regeneron Pharmaceuticals

Regeneron Pharmaceuticals REGN is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement.

Analysts estimate that Regeneron Pharmaceuticals will likely report an Earnings Per Share (EPS) of $18.11.

Regeneron Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $5.88, which was followed by a 5.57% drop in the share price the next day.

Here's a look at Regeneron Pharmaceuticals's past performance and the resulting price change:

Stock Performance

Shares of Regeneron Pharmaceuticals were trading at $622.85 as of February 02. Over the last 52-week period, shares are up 24.21%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.